Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine.

Folegatti PM, Bellamy D, Roberts R, Powlson J, Edwards NJ, Mair CF, Bowyer G, Poulton I, Mitton CH, Green N, Berrie E, Lawrie AM, Hill AVS, Ewer KJ, Hermon-Taylor J, Gilbert SC.

Vaccines (Basel). 2019 May 15;7(2). pii: E40. doi: 10.3390/vaccines7020040.

2.

HLA-E: exploiting pathogen-host interactions for vaccine development.

Sharpe HR, Bowyer G, Brackenridge S, Lambe T.

Clin Exp Immunol. 2019 May;196(2):167-177. doi: 10.1111/cei.13292. Epub 2019 Apr 9. Review.

3.

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.

Tiono AB, Nébié I, Anagnostou N, Coulibaly AS, Bowyer G, Lam E, Bougouma EC, Ouedraogo A, Yaro JBB, Barry A, Roberts R, Rampling T, Bliss C, Hodgson S, Lawrie A, Ouedraogo A, Imoukhuede EB, Ewer KJ, Viebig NK, Diarra A, Leroy O, Bejon P, Hill AVS, Sirima SB.

PLoS One. 2018 Dec 12;13(12):e0208328. doi: 10.1371/journal.pone.0208328. eCollection 2018.

4.

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.

Venkatraman N, Ndiaye BP, Bowyer G, Wade D, Sridhar S, Wright D, Powlson J, Ndiaye I, Dièye S, Thompson C, Bakhoum M, Morter R, Capone S, Del Sorbo M, Jamieson S, Rampling T, Datoo M, Roberts R, Poulton I, Griffiths O, Ballou WR, Roman F, Lewis DJM, Lawrie A, Imoukhuede E, Gilbert SC, Dieye TN, Ewer KJ, Mboup S, Hill AVS.

J Infect Dis. 2019 Apr 8;219(8):1187-1197. doi: 10.1093/infdis/jiy639.

5.

Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP.

Rampling T, Ewer KJ, Bowyer G, Edwards NJ, Wright D, Sridhar S, Payne R, Powlson J, Bliss C, Venkatraman N, Poulton ID, de Graaf H, Gbesemete D, Grobbelaar A, Davies H, Roberts R, Angus B, Ivinson K, Weltzin R, Rajkumar BY, Wille-Reece U, Lee C, Ockenhouse C, Sinden RE, Gerry SC, Lawrie AM, Vekemans J, Morelle D, Lievens M, Ballou RW, Lewis DJM, Cooke GS, Faust SN, Gilbert S, Hill AVS.

NPJ Vaccines. 2018 Oct 9;3:49. doi: 10.1038/s41541-018-0084-2. eCollection 2018.

6.

Prime and target immunization protects against liver-stage malaria in mice.

Gola A, Silman D, Walters AA, Sridhar S, Uderhardt S, Salman AM, Halbroth BR, Bellamy D, Bowyer G, Powlson J, Baker M, Venkatraman N, Poulton I, Berrie E, Roberts R, Lawrie AM, Angus B, Khan SM, Janse CJ, Ewer KJ, Germain RN, Spencer AJ, Hill AVS.

Sci Transl Med. 2018 Sep 26;10(460). pii: eaap9128. doi: 10.1126/scitranslmed.aap9128.

PMID:
30257955
7.

CXCR3+ T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria.

Bowyer G, Grobbelaar A, Rampling T, Venkatraman N, Morelle D, Ballou RW, Hill AVS, Ewer KJ.

Front Immunol. 2018 Jul 25;9:1660. doi: 10.3389/fimmu.2018.01660. eCollection 2018.

8.

Activation-induced Markers Detect Vaccine-Specific CD4⁺ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials.

Bowyer G, Rampling T, Powlson J, Morter R, Wright D, Hill AVS, Ewer KJ.

Vaccines (Basel). 2018 Jul 31;6(3). pii: E50. doi: 10.3390/vaccines6030050.

9.

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.

Bliss CM, Bowyer G, Anagnostou NA, Havelock T, Snudden CM, Davies H, de Cassan SC, Grobbelaar A, Lawrie AM, Venkatraman N, Poulton ID, Roberts R, Mange PB, Choudhary P, Faust SN, Colloca S, Gilbert SC, Nicosia A, Hill AVS, Ewer KJ.

Sci Rep. 2018 Feb 21;8(1):3390. doi: 10.1038/s41598-018-21630-4.

10.

Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial.

Mensah VA, Roetynck S, Kanteh EK, Bowyer G, Ndaw A, Oko F, Bliss CM, Jagne YJ, Cortese R, Nicosia A, Roberts R, D'Alessio F, Leroy O, Faye B, Kampmann B, Cisse B, Bojang K, Gerry S, Viebig NK, Lawrie AM, Clarke E, Imoukhuede EB, Ewer KJ, Hill AVS, Afolabi MO.

Front Immunol. 2017 Nov 20;8:1551. doi: 10.3389/fimmu.2017.01551. eCollection 2017.

11.

An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens.

Rodríguez-Galán A, Salman AM, Bowyer G, Collins KA, Longley RJ, Brod F, Ulaszewska M, Ewer KJ, Janse CJ, Khan SM, Hafalla JC, Hill AVS, Spencer AJ.

Sci Rep. 2017 Dec 5;7(1):17011. doi: 10.1038/s41598-017-17274-5.

12.

Malaria-induced interferon-γ drives the expansion of Tbethi atypical memory B cells.

Obeng-Adjei N, Portugal S, Holla P, Li S, Sohn H, Ambegaonkar A, Skinner J, Bowyer G, Doumbo OK, Traore B, Pierce SK, Crompton PD.

PLoS Pathog. 2017 Sep 27;13(9):e1006576. doi: 10.1371/journal.ppat.1006576. eCollection 2017 Sep.

13.

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™.

Venkatraman N, Anagnostou N, Bliss C, Bowyer G, Wright D, Lövgren-Bengtsson K, Roberts R, Poulton I, Lawrie A, Ewer K, V S Hill A.

Vaccine. 2017 Oct 27;35(45):6208-6217. doi: 10.1016/j.vaccine.2017.09.028. Epub 2017 Sep 21.

PMID:
28941620
14.

A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?

Lambe T, Bowyer G, Ewer KJ.

Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721). pii: 20160295. doi: 10.1098/rstb.2016.0295. Review.

15.

Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.

Bliss CM, Drammeh A, Bowyer G, Sanou GS, Jagne YJ, Ouedraogo O, Edwards NJ, Tarama C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Afolabi MO, Tiono AB, Yaro JB, Adetifa UJ, Hodgson SH, Anagnostou NA, Roberts R, Duncan CJ, Cortese R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampmann B, Imoukhuede EB, Sirima SB, Bojang K, Hill AV, Nébié I, Ewer KJ.

Mol Ther. 2017 Feb 1;25(2):547-559. doi: 10.1016/j.ymthe.2016.11.003.

16.

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.

Rampling T, Ewer KJ, Bowyer G, Bliss CM, Edwards NJ, Wright D, Payne RO, Venkatraman N, de Barra E, Snudden CM, Poulton ID, de Graaf H, Sukhtankar P, Roberts R, Ivinson K, Weltzin R, Rajkumar BY, Wille-Reece U, Lee CK, Ockenhouse CF, Sinden RE, Gerry S, Lawrie AM, Vekemans J, Morelle D, Lievens M, Ballou RW, Cooke GS, Faust SN, Gilbert S, Hill AV.

J Infect Dis. 2016 Sep 1;214(5):772-81. doi: 10.1093/infdis/jiw244. Epub 2016 Jun 15.

17.

Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid.

Lambe T, Rampling T, Samuel D, Bowyer G, Ewer KJ, Venkatraman N, Edmans M, Dicks S, Hill AV, Tedder RS, Gilbert SC.

Open Forum Infect Dis. 2016 Feb 22;3(1):ofw031. doi: 10.1093/ofid/ofw031. eCollection 2016 Jan.

18.

Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults.

Ogwang C, Kimani D, Edwards NJ, Roberts R, Mwacharo J, Bowyer G, Bliss C, Hodgson SH, Njuguna P, Viebig NK, Nicosia A, Gitau E, Douglas S, Illingworth J, Marsh K, Lawrie A, Imoukhuede EB, Ewer K, Urban BC, Hill AVS, Bejon P; MVVC group.

Sci Transl Med. 2015 May 6;7(286):286re5. doi: 10.1126/scitranslmed.aaa2373.

19.

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

Ewer K, Rampling T, Venkatraman N, Bowyer G, Wright D, Lambe T, Imoukhuede EB, Payne R, Fehling SK, Strecker T, Biedenkopf N, Krähling V, Tully CM, Edwards NJ, Bentley EM, Samuel D, Labbé G, Jin J, Gibani M, Minhinnick A, Wilkie M, Poulton I, Lella N, Roberts R, Hartnell F, Bliss C, Sierra-Davidson K, Powlson J, Berrie E, Tedder R, Roman F, De Ryck I, Nicosia A, Sullivan NJ, Stanley DA, Mbaya OT, Ledgerwood JE, Schwartz RM, Siani L, Colloca S, Folgori A, Di Marco S, Cortese R, Wright E, Becker S, Graham BS, Koup RA, Levine MM, Volkmann A, Chaplin P, Pollard AJ, Draper SJ, Ballou WR, Lawrie A, Gilbert SC, Hill AV.

N Engl J Med. 2016 Apr 28;374(17):1635-46. doi: 10.1056/NEJMoa1411627. Epub 2015 Jan 28.

20.

Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.

Hodgson SH, Ewer KJ, Bliss CM, Edwards NJ, Rampling T, Anagnostou NA, de Barra E, Havelock T, Bowyer G, Poulton ID, de Cassan S, Longley R, Illingworth JJ, Douglas AD, Mange PB, Collins KA, Roberts R, Gerry S, Berrie E, Moyle S, Colloca S, Cortese R, Sinden RE, Gilbert SC, Bejon P, Lawrie AM, Nicosia A, Faust SN, Hill AV.

J Infect Dis. 2015 Apr 1;211(7):1076-86. doi: 10.1093/infdis/jiu579. Epub 2014 Oct 21.

21.

Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.

Kimani D, Jagne YJ, Cox M, Kimani E, Bliss CM, Gitau E, Ogwang C, Afolabi MO, Bowyer G, Collins KA, Edwards N, Hodgson SH, Duncan CJ, Spencer AJ, Knight MG, Drammeh A, Anagnostou NA, Berrie E, Moyle S, Gilbert SC, Soipei P, Okebe J, Colloca S, Cortese R, Viebig NK, Roberts R, Lawrie AM, Nicosia A, Imoukhuede EB, Bejon P, Chilengi R, Bojang K, Flanagan KL, Hill AV, Urban BC, Ewer KJ.

Mol Ther. 2014 Nov;22(11):1992-2003. doi: 10.1038/mt.2014.109. Epub 2014 Jun 16.

22.

The synovial fold of the distal tibiofibular joint: A morphometric study.

O'Sullivan E, Bowyer G, Webb AL.

Clin Anat. 2013 Jul;26(5):630-7. doi: 10.1002/ca.22140. Epub 2012 Aug 7.

PMID:
22887077
23.

Injuries sustained at a temporary ice-skating rink: prospective study of the Winchester experience 2007-2008.

Kelsall NK, Bowyer GW.

Injury. 2009 Dec;40(12):1276-8. doi: 10.1016/j.injury.2009.02.006. Epub 2009 Jun 13.

PMID:
19524911
24.

Débridement of extremity war wounds.

Bowyer G.

J Am Acad Orthop Surg. 2006;14(10 Spec No.):S52-6. Review.

PMID:
17003208
25.

Pressure characteristics of pelvic binders.

Jowett AJ, Bowyer GW.

Injury. 2007 Jan;38(1):118-21.

PMID:
16765956
26.
27.

Septic arthritis of the knee by Salmonella montevideo.

Katsoulis E, Pallett A, Bowyer GW.

Ann R Coll Surg Engl. 2004 Jul;86(4):272-4.

28.

Effects of fatigue on ankle stability and proprioception in university sportspeople.

Brown JP, Bowyer GW.

Br J Sports Med. 2002 Aug;36(4):310. No abstract available.

29.

Small fragment wounds: biophysics, pathophysiology and principles of management.

Hill PF, Edwards DP, Bowyer GW.

J R Army Med Corps. 2001 Feb;147(1):41-51. Review.

PMID:
11307676
30.

Greatly delayed complication of medial epicondyle injury.

Clarke MD, Hobbs CM, Bowyer GW.

Injury. 1998 Oct;29(8):636-9. No abstract available.

PMID:
10209600
31.

Management of gunshot wounds of the limbs.

Bowyer GW, Rossiter ND.

J Bone Joint Surg Br. 1997 Nov;79(6):1031-6. Review. No abstract available.

PMID:
9393926
32.

Management of small fragment wounds in modern warfare: a return to Hunterian principles?

Bowyer GW.

Ann R Coll Surg Engl. 1997 May;79(3):175-82. Review. No abstract available.

33.

Management of small fragment wounds: experience from the Afghan border.

Bowyer GW.

J Trauma. 1996 Mar;40(3 Suppl):S170-2.

PMID:
8606403
34.

Small fragment wounds: biophysics and pathophysiology.

Bowyer GW, Cooper GJ, Rice P.

J Trauma. 1996 Mar;40(3 Suppl):S159-64.

PMID:
8606400
35.
36.

Fractures of the femur in children.

Bowyer GW, Clarke NM.

J Bone Joint Surg Am. 1995 Nov;77(11):1784-5. No abstract available.

PMID:
7593090
37.

Complications of paediatric femoral nailing.

Bowyer GW, Clarke NM.

J Bone Joint Surg Br. 1995 Jul;77(4):666-7. No abstract available.

PMID:
7615625
38.

Management of small fragment wounds in war: current research.

Bowyer GW, Cooper GJ, Rice P.

Ann R Coll Surg Engl. 1995 Mar;77(2):131-4.

39.
40.

Pattern of injury in those dying from traumatic amputation caused by bomb blast.

Hull JB, Bowyer GW, Cooper GJ, Crane J.

Br J Surg. 1994 Aug;81(8):1132-5.

PMID:
7953338
41.

Antibiotic release from impregnated pellets and beads.

Bowyer GW, Cumberland N.

J Trauma. 1994 Mar;36(3):331-5.

PMID:
8145311
42.

Gunshot wounds of the colon: ballistic considerations.

Bowyer GW.

Ann R Coll Surg Engl. 1993 Nov;75(6):450. No abstract available.

43.

Gulf war wounds: application of the Red Cross wound classification.

Bowyer GW, Stewart MP, Ryan JM.

Injury. 1993 Oct;24(9):597-600.

PMID:
8288378
45.

Pressure in plaster backslabs after surgery for ankle fractures.

Bowyer GW, Iu M, Reynard JM.

Injury. 1993 Feb;24(2):121-2.

PMID:
8505118
46.

Placental alkaline phosphatase in seminoma.

Bowyer GW, Dhatt GS.

Eur J Surg Oncol. 1991 Aug;17(4):419-20. No abstract available.

PMID:
1874301
47.

Placental alkaline phosphatase in seminoma.

Bowyer GW, Dhatt GS.

Br J Hosp Med. 1991 Jul;46(1):18. No abstract available.

PMID:
1868303
48.

Anterior cruciate ligament reconstruction using the Gore-tex ligament.

Bowyer GW, Matthews SJ.

J R Army Med Corps. 1991 Jun;137(2):69-75.

PMID:
1875321
49.

Survival of a finger after ring avulsion injury to both main digital arteries.

Bowyer GW.

Injury. 1990 May;21(3):186-7. No abstract available.

PMID:
2401555
50.

Sunburn of the head in south Georgia.

Bowyer GW.

J R Army Med Corps. 1988 Jun;134(2):104. No abstract available.

PMID:
3418603

Supplemental Content

Loading ...
Support Center